Summary
Biliary atresia (BA) is a unique neonatal disease, presenting with complete obstruction of the extrahepatic biliary tree within the first 3 months of life. Current therapy requires a hepatic portoenterostomy within the first months of life; however, progressive intrahepatic bile duct injury, sclerosis, and obstruction lead to cirrhosis and the need for liver transplantation in the majority of patients. Medical treatments are inadequate largely because the pathogenesis of BA is poorly understood. Two major forms of BA have been described. The embryonic form is associated with other congenital malformations and presumably represents failure of normal bile duct formation. Mutations or epigenetic modifications in genes involving laterality and bile duct morphogenesis or ductal plate regression are proposed to be involved. The perinatal form is not associated with other malformations and is proposed to be caused by an immune or an autoimmune response to a perinatal insult (e.g., cholangiotropic viral infection). There is conflicting evidence for the role of several viruses, although the mouse rhesus rotavirus model of BA makes human rotavirus and reovirus intriguing candidates. Future investigations in coming years are anticipated to unlock the mysteries surrounding the etiology of BA with the promise of new therapeutic strategies and potential prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- APC:
-
antigen-presenting cell
- BA:
-
biliary atresia
- CD:
-
clusters of differentiation
- CMV:
-
cytomegalovirus
- HLA:
-
human leukocyte antigen
- IFN:
-
interferon
- IL:
-
interleukin
- INV:
-
inversin
- LBW:
-
low birth weight
- MHC:
-
major histocompatibility complex
- OR:
-
odds ratio
- RNA:
-
ribonucleic acid
- RR:
-
risk ratio
- RT-PCR:
-
reverse transcriptase-polymerase chain reaction
- SGA:
-
small for gestational age
- TNF:
-
tumor necrosis factor
References
Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: Current concepts. J Pediatr Gastroenterol Nutr 2003;37, 4–21.
Ohi R. Biliary atresia. A surgical perspective. Clin Liver Dis 2000;4, 779–804.
Schweizer P. Treatment of extrahepatic biliary atresia: Results and long-term prognosis after hepatic portoenterostomy. Pediatr Surg 1986;1, 30–36.
Serinet MO, Wildhaber BE, Broué P et al. Impact of age at Kasai operation on its results in late childhood and adolescence: A rational basis for biliary atresia screening. Pediatrics 2009;123, 1280–1286.
Karrer FM, Bensard DD. Neonatal cholestasis. Semin Pediatr Surg 2000;9, 166–169.
Chardot C, Carton M, Spire-Bendelac N. Epidemiology of biliary atresia in France: A national study 1986–96. J Hepatol 1999;31, 1006–1013.
Karrer FM, Price MR, Bensard DD et al. Long-term results with the Kasai operation for biliary atresia. Arch Surg 1996;131, 493–496.
Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: A disease or a phenotype? Hepatology 2002;35, 1297–1304.
Mazziotti MV, Willis LK, Heuckeroth RO et al. Anomalous development of the hepatobiliary system in the Inv mouse. Hepatology 1999;30, 372–378.
Yokoyama T, Copeland NG, Jenkins NA et al. Reversal of left-right asymmetry: A situs inversus mutation. Science 1993;260, 679–682.
Schon P, Tsuchiya K, Lenoir D et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet 2002;110, 157–165.
Otto EA, Schermer B, Obara T et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat Genet 2003;34, 413–420.
Johnson CA, Gissen P, Sergi C. Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes. J Med Genet 2003;40, 311–319.
Low Y, Vijayan V, Tan CE. The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: An immunohistochemical study. J Pediatr 2001;139, 320–322.
Bamford RN, Roessler E, Burdine RD et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000;26, 365–369.
Jacquemin E, Cresteil D, Raynaud N, Hadchouel M. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2002;34, 326–327.
Ware SM, Peng J, Zhu L et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 2004;74, 93–105.
Zhang DY, Sabla G, Shivakumar P et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 2004;39, 954–962.
Schwarz KB, Shepherd R, Magee J et al. Clinical and demographic features of three major biliary atresia phenotypes in the BARC study. Hepatology 2008;48(Suppl), 1028A–1029A.
Vijayani V, Tan CE. Developing human biliary system in three dimension. Anat Rec 1997;249, 389–398.
Lemaigre FP. Development of the biliary tract. Mech Dev 2003;120, 81–87.
Clotman F, Lannoy VJ, Reber M et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 2002;129, 1819–1828.
Coffinier C, Gresh L, Fiette L et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 2002;129, 1829–1838.
Clotman F, Libbrecht L, Gresh L et al. Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development. J Hepatol 2003;39, 686–692.
Kohsaka T, Yuan ZR, Guo SX et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 2002;36, 904–912.
Tan CE, Moscoso GJ. The developing human biliary system at the porta hepatis level between 11 and 25 weeks of gestation: A way to understanding biliary atresia. Part 2. Pathol Int 1994;44, 600–610.
Rolleston HD, Hayne LB. A case of congenital hepatic cirrhosis with obliterative cholangitis (congenital obliteration of the bile ducts). Br Med J 1901; 1, 758–760.
Gosseye S, Otte JB, De Meyer R, Maldague P. A histological study of extrahepatic biliary atresia. Acta Paediatr Belg 1977;30, 85–90.
Bill AH, Haas JE, Foster GL. Biliary atresia: Histopathologic observations and reflections upon its natural history. J Pediatr Surg 1977;12, 977–982.
Ohya T, Fujimoto T, Shimomura H, Miyano T. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 1995;30, 515–518.
Ahmed AF, Ohtani H, Nio M et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: A clinicopathological analysis. J Pathol 2001;193, 383–389.
Mack CL, Tucker RM, Sokol RJ et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004;56, 79–87.
Davenport M, Gonde C, Redkar R et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 2001;36, 1017–1025.
Dillon P, Belchis D, Tracy T et al. Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol 1994;145, 263–267.
Bezerra JA, Tiao G, Ryckman FC et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360, 1653–1659.
Shivakumar P, Campbell KM, Sabla GE et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114, 322–329.
Kobayashi H, Li Z, Yamataka A et al. Role of immunologic costimulatory factors in the pathogenesis of biliary atresia. J Pediatr Surg 2003;38, 892–896.
Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med 1997;181, 33–40.
Broome U, Nemeth A, Hultcrantz R, Scheynius A. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler’s disease. J Hepatol 1997;26, 857–862.
Kobayashi H, Puri P, O‘Briain DS et al. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg 1997;32, 590–593.
Tracy TF, Dillon P, Fox ES et al. The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution. J Pediatr Surg 1996;31, 121–125; discussion 125–126.
Urushihara N, Iwagaki H, Yagi T et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000;35, 446–449.
Funaki N, Sasano H, Shizawa S et al. Apoptosis and cell proliferation in biliary atresia. J Pathol 1998;186, 429–433.
Liu C, Chiu JH, Chin T et al. Expression of fas ligand on bile ductule epithelium in biliary atresia – a poor prognostic factor. J Pediatr Surg 2000;35, 1591–1596.
Jafri M, Donnelly B, Bondoc A et al. Cholangiocyte secretion of chemokines in experimental biliary atresia. J Pediatr Surg. 2009;44(3), 500–507.
Barnes BH, Tucker RM, Wehrmann F et al. Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int 2008; Nov 25. [Epub ahead of print].
Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: An opening or a diversion? J Pediatr Gastroenterol Nutr 1993;16, 111–113.
Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis 2001;21, 517–524.
Eagar T, Tompkins S, Miller S. Helper T-cell subsets and control of the inflammatory response. In: Rich R, Fleisher T, Shearer W, Kotzin B, Schroeder H Jr., (eds.) Clinical Immunology Principles and Practice, 2001. London: Mosby, pp. 16.11–16.12.
Vasiliauskas E, Targan S, Cobb L et al. Biliary atresia – an autoimmune disorder? Hepatology 1995;22, 87.
Burch J, Sokol RJ, Narkewicz MR et al. The role of maternal antibodies in cholestatic liver disease in infants: A new isolated finding in neonatal lupus? J Pediatr Gastroenterol Nutr 2000;31(Suppl 2), S108.
Kerkar N, Hadzic N, Davies ET et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351, 409–413.
Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001;32, 131–136.
Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 2000. Philadelphia: W.B. Saunders, pp. vii, 553.
Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991;11, 1–4.
Donaldson PT, Manns MP. Immunogenetics of liver disease. In Benhamou J-P, McIntyre N, Rizetto M, Rodes J. (eds) Oxford Textbook of Clinical Hepatology, 1999. Oxford; New York: Oxford University Press, 173–188.
Manabe K, Donaldson PT, Underhill JA et al. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis. Hepatology 1993;18, 1334–1337.
Rosenthal P, Woolf GM, Tyan DB. A striking association between HLA-C and biliary atresia. Gastroenterology 1995;108, A1158.
Silveira TR, Salzano FM, Donaldson PT et al. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1993;16, 114–117.
A-Kader HH, El-Ayyouti M, Hawas S et al. HLA in Egyptian children with biliary atresia. J Pediatr 2002;141, 432–433.
Donaldson PT, Clare M, Constantini PK et al. HLA and cytokine gene polymorphisms in biliary atresia. Liver 2002;22, 213–219.
Yoon PW, Bresee JS, Olney RS et al. Epidemiology of biliary atresia: A population-based study. Pediatrics 1997;99, 376–382.
Strickland AD, Shannon K. Studies in the etiology of extrahepatic biliary atresia: Time–space clustering. J Pediatr 1982;100, 749–753.
Caton AR, Druschel CM, McNutt LA. The epidemiology of extrahepatic biliary atresia in New York State, 1983-98. Paediatr Perinat Epidemiol 2004;18, 97–105.
Fischler B, Haglund B, Hjern A. A population-based study on the incidence and possible pre- and perinatal etiologic risk factors of biliary atresia. J Pediatr 2002;141, 217–222.
Bangaru B, Morecki R, Glaser JH et al. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 1980;43, 456–462.
Morecki R, Glaser JH, Cho S et al. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982;307, 481–484.
Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 1984;105, 912–915.
Brown WR, Sokol RJ, Levin MJ et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr 1988;113, 670–676.
Dussaix E, Hadchouel M, Tardieu M, Alagille D. Biliary atresia and reovirus type 3 infection. N Engl J Med 1984;310, 658.
Rosenberg DP, Morecki R, Lollini LO et al. Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology 1983;3, 577–580.
Morecki R, Glaser JH, Johnson AB, Kress Y. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: Ultrastructural and immunocytochemical study. Hepatology 1984;4, 1137–1142.
Steele MI, Marshall CM, Lloyd RE, Randolph VE. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995;21, 697–702.
Saito T, Shinozaki K, Matsunaga T et al. Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct. J Hepatol 2004;40, 203–211.
Tyler KL, Sokol RJ, Oberhaus SM et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998;27, 1475–1482.
Riepenhoff-Talty M, Gouvea V, Evans MJ et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996;174, 8–15.
Bobo L, Ojeh C, Chiu D et al. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 1997;41, 229–234.
Riepenhoff-Talty M, Schaekel K, Clark HF et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993;33, 394–399.
Petersen C, Biermanns D, Kuske M et al. New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg 1997;32, 1190–1195.
Harada K, Sato Y, Itatsu K et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 2007;46, 1146–1154.
Huang YH, Chou MH, Du YY et al. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest 2007;87, 66–74.
Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 1996;97, 828–831.
Oliveira NL, Kanawaty FR, Costa SC, Hessel G. Infection by cytomegalovirus in patients with neonatal cholestasis. Arq Gastroenterol 2002;39, 132–136.
Fischler B, Ehrnst A, Forsgren M et al. The viral association of neonatal cholestasis in Sweden: A possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998;27, 57–64.
Jevon GP, Dimmick JE. Biliary atresia and cytomegalovirus infection: A DNA study. Pediatr Dev Pathol 1999;2, 11–14.
Drut R, Drut RM, Gomez MA et al. Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998;27, 530–535.
Domiati-Saad R, Dawson DB, Margraf LR et al. Cytomegalovirus and human herpes virus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol 2000;3, 367–373.
Tracy TF, Dillon P, Fox ES et al. The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution. J Pediatr Surg 1996;31, 121–125.
Ahmed AF, Nio M, Ohtani H et al. In situ CD14 expression in biliary atresia: Comparison between early and late stages. J Pediatr Surg 2001;36, 240–243.
Acknowledgment
Supported in part by grants from the National Institutes of Health (R01 DK38446, UO1 DK062453, U54 RR019455, M01 RR00069, and UL1RR025780) and the Abby Bennett Liver Research Fund.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sokol, R.J., Mack, C.L. (2010). Biliary Atresia and the Ductal Plate. In: Murray, K., Larson, A. (eds) Fibrocystic Diseases of the Liver. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60327-524-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-524-8_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-523-1
Online ISBN: 978-1-60327-524-8
eBook Packages: MedicineMedicine (R0)